Click for best price
PD1 PDL1 Drug Market Size, Share 2024
| Market size in 2023 |
US$ 24.3 billion
|
Forecast Market size by 2030 |
US$ 48.5 billion
|
| Growth Rate |
CAGR of 10.1% |
Number of Pages |
117 Pages |
The global PD-1 and PD-L1 Drug market was valued at US$ 24.3 billion in 2023 and is projected to reach US$ 48.5 billion by 2030, at a CAGR of 10.1% during the forecast period.
The USA market for Global PD-1 and PD-L1 Drug market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global PD-1 and PD-L1 Drug market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global PD-1 and PD-L1 Drug market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
PD-1 Monoclonal Antibody Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of PD-1 and PD-L1 Drug include Bristol Myers Squibb, Merck & Co., Inc., F. Hoffmann -La Roche Ltd, AstraZeneca, Sanofi, Pfizer Inc, Lilly, Novartis AG and GSK, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
PD-1/PD-L1 is an important part of the human immune system-a drug target on T cells. Drugs designed for this target can activate the immune effect of T cells on tumor cells, thereby awakening the patient's own anti-cancer effect. tumor effect.
This report aims to provide a comprehensive presentation of the global market for PD-1 and PD-L1 Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-1 and PD-L1 Drug. This report contains market size and forecasts of PD-1 and PD-L1 Drug in global, including the following market information:
- Global PD-1 and PD-L1 Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global PD-1 and PD-L1 Drug Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five PD-1 and PD-L1 Drug companies in 2023 (%)
We has surveyed the PD-1 and PD-L1 Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PD-1 and PD-L1 Drug Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global PD-1 and PD-L1 Drug Market Segment Percentages, by Type, 2023 (%)
- PD-1 Monoclonal Antibody
- PD-L1 Monoclonal Antibody
Global PD-1 and PD-L1 Drug Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global PD-1 and PD-L1 Drug Market Segment Percentages, by Application, 2023 (%)
- Liver Cancer
- Esophageal Cancer
- Nasal Cancer
- Stomach Cancer
- Other
Global PD-1 and PD-L1 Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global PD-1 and PD-L1 Drug Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies PD-1 and PD-L1 Drug revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies PD-1 and PD-L1 Drug revenues share in global market, 2023 (%)
- Key companies PD-1 and PD-L1 Drug sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies PD-1 and PD-L1 Drug sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol Myers Squibb
- Merck & Co., Inc.
- F. Hoffmann -La Roche Ltd
- AstraZeneca
- Sanofi
- Pfizer Inc
- Lilly
- Novartis AG
- GSK
- Junshi Biosciences
- Akeso, Inc
- BeiGene
- Innovent
- Jiangsu Hengrui Medicine Co.,Ltd
- Cstone
- Henlius
- Simcere Pharmaceutical Group Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of PD-1 and PD-L1 Drug, market overview.
Chapter 2: Global PD-1 and PD-L1 Drug market size in revenue and volume.
Chapter 3: Detailed analysis of PD-1 and PD-L1 Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of PD-1 and PD-L1 Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global PD-1 and PD-L1 Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
PD-1 and PD-L1 Drug Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 24.3 billion
|
| Forecast Market size by 2030 |
US$ 48.5 billion
|
| Growth Rate |
CAGR of 10.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
117 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 PD-1 and PD-L1 Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PD-1 and PD-L1 Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PD-1 and PD-L1 Drug Overall Market Size
2.1 Global PD-1 and PD-L1 Drug Market Size: 2023 VS 2030
2.2 Global PD-1 and PD-L1 Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global PD-1 and PD-L1 Drug Sales: 2019-2030
3 Company Landscape
3.1 Top PD-1 and PD-L1 Drug Players in Global Market
3.2 Top Global PD-1 and PD-L1 Drug Companies Ranked by Revenue
3.3 Global PD-1 and PD-L1 Drug Revenue by Companies
3.4 Global PD-1 and PD-L1 Drug Sales by Companies
3.5 Global PD-1 and PD-L1 Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 PD-1 and PD-L1 Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers PD-1 and PD-L1 Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 PD-1 and PD-L1 Drug Players in Global Market
3.8.1 List of Global Tier 1 PD-1 and PD-L1 Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 PD-1 and PD-L1 Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global PD-1 and PD-L1 Drug Market Size Markets, 2023 & 2030
4.1.2 PD-1 Monoclonal Antibody
4.1.3 PD-L1 Monoclonal Antibody
4.2 By Type - Global PD-1 and PD-L1 Drug Revenue & Forecasts
4.2.1 By Type - Global PD-1 and PD-L1 Drug Revenue, 2019-2024
4.2.2 By Type - Global PD-1 and PD-L1 Drug Revenue, 2025-2030
4.2.3 By Type - Global PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
4.3 By Type - Global PD-1 and PD-L1 Drug Sales & Forecasts
4.3.1 By Type - Global PD-1 and PD-L1 Drug Sales, 2019-2024
4.3.2 By Type - Global PD-1 and PD-L1 Drug Sales, 2025-2030
4.3.3 By Type - Global PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
4.4 By Type - Global PD-1 and PD-L1 Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global PD-1 and PD-L1 Drug Market Size, 2023 & 2030
5.1.2 Liver Cancer
5.1.3 Esophageal Cancer
5.1.4 Nasal Cancer
5.1.5 Stomach Cancer
5.1.6 Other
5.2 By Application - Global PD-1 and PD-L1 Drug Revenue & Forecasts
5.2.1 By Application - Global PD-1 and PD-L1 Drug Revenue, 2019-2024
5.2.2 By Application - Global PD-1 and PD-L1 Drug Revenue, 2025-2030
5.2.3 By Application - Global PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
5.3 By Application - Global PD-1 and PD-L1 Drug Sales & Forecasts
5.3.1 By Application - Global PD-1 and PD-L1 Drug Sales, 2019-2024
5.3.2 By Application - Global PD-1 and PD-L1 Drug Sales, 2025-2030
5.3.3 By Application - Global PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
5.4 By Application - Global PD-1 and PD-L1 Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global PD-1 and PD-L1 Drug Market Size, 2023 & 2030
6.2 By Region - Global PD-1 and PD-L1 Drug Revenue & Forecasts
6.2.1 By Region - Global PD-1 and PD-L1 Drug Revenue, 2019-2024
6.2.2 By Region - Global PD-1 and PD-L1 Drug Revenue, 2025-2030
6.2.3 By Region - Global PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
6.3 By Region - Global PD-1 and PD-L1 Drug Sales & Forecasts
6.3.1 By Region - Global PD-1 and PD-L1 Drug Sales, 2019-2024
6.3.2 By Region - Global PD-1 and PD-L1 Drug Sales, 2025-2030
6.3.3 By Region - Global PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America PD-1 and PD-L1 Drug Revenue, 2019-2030
6.4.2 By Country - North America PD-1 and PD-L1 Drug Sales, 2019-2030
6.4.3 US PD-1 and PD-L1 Drug Market Size, 2019-2030
6.4.4 Canada PD-1 and PD-L1 Drug Market Size, 2019-2030
6.4.5 Mexico PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe PD-1 and PD-L1 Drug Revenue, 2019-2030
6.5.2 By Country - Europe PD-1 and PD-L1 Drug Sales, 2019-2030
6.5.3 Germany PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5.4 France PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5.5 U.K. PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5.6 Italy PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5.7 Russia PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5.8 Nordic Countries PD-1 and PD-L1 Drug Market Size, 2019-2030
6.5.9 Benelux PD-1 and PD-L1 Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia PD-1 and PD-L1 Drug Revenue, 2019-2030
6.6.2 By Region - Asia PD-1 and PD-L1 Drug Sales, 2019-2030
6.6.3 China PD-1 and PD-L1 Drug Market Size, 2019-2030
6.6.4 Japan PD-1 and PD-L1 Drug Market Size, 2019-2030
6.6.5 South Korea PD-1 and PD-L1 Drug Market Size, 2019-2030
6.6.6 Southeast Asia PD-1 and PD-L1 Drug Market Size, 2019-2030
6.6.7 India PD-1 and PD-L1 Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America PD-1 and PD-L1 Drug Revenue, 2019-2030
6.7.2 By Country - South America PD-1 and PD-L1 Drug Sales, 2019-2030
6.7.3 Brazil PD-1 and PD-L1 Drug Market Size, 2019-2030
6.7.4 Argentina PD-1 and PD-L1 Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa PD-1 and PD-L1 Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa PD-1 and PD-L1 Drug Sales, 2019-2030
6.8.3 Turkey PD-1 and PD-L1 Drug Market Size, 2019-2030
6.8.4 Israel PD-1 and PD-L1 Drug Market Size, 2019-2030
6.8.5 Saudi Arabia PD-1 and PD-L1 Drug Market Size, 2019-2030
6.8.6 UAE PD-1 and PD-L1 Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Company Summary
7.1.2 Bristol Myers Squibb Business Overview
7.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Major Product Offerings
7.1.4 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.1.5 Bristol Myers Squibb Key News & Latest Developments
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Company Summary
7.2.2 Merck & Co., Inc. Business Overview
7.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Major Product Offerings
7.2.4 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.2.5 Merck & Co., Inc. Key News & Latest Developments
7.3 F. Hoffmann -La Roche Ltd
7.3.1 F. Hoffmann -La Roche Ltd Company Summary
7.3.2 F. Hoffmann -La Roche Ltd Business Overview
7.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Major Product Offerings
7.3.4 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.3.5 F. Hoffmann -La Roche Ltd Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca PD-1 and PD-L1 Drug Major Product Offerings
7.4.4 AstraZeneca PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi PD-1 and PD-L1 Drug Major Product Offerings
7.5.4 Sanofi PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.5.5 Sanofi Key News & Latest Developments
7.6 Pfizer Inc
7.6.1 Pfizer Inc Company Summary
7.6.2 Pfizer Inc Business Overview
7.6.3 Pfizer Inc PD-1 and PD-L1 Drug Major Product Offerings
7.6.4 Pfizer Inc PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.6.5 Pfizer Inc Key News & Latest Developments
7.7 Lilly
7.7.1 Lilly Company Summary
7.7.2 Lilly Business Overview
7.7.3 Lilly PD-1 and PD-L1 Drug Major Product Offerings
7.7.4 Lilly PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.7.5 Lilly Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG PD-1 and PD-L1 Drug Major Product Offerings
7.8.4 Novartis AG PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.8.5 Novartis AG Key News & Latest Developments
7.9 GSK
7.9.1 GSK Company Summary
7.9.2 GSK Business Overview
7.9.3 GSK PD-1 and PD-L1 Drug Major Product Offerings
7.9.4 GSK PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.9.5 GSK Key News & Latest Developments
7.10 Junshi Biosciences
7.10.1 Junshi Biosciences Company Summary
7.10.2 Junshi Biosciences Business Overview
7.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Major Product Offerings
7.10.4 Junshi Biosciences PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.10.5 Junshi Biosciences Key News & Latest Developments
7.11 Akeso, Inc
7.11.1 Akeso, Inc Company Summary
7.11.2 Akeso, Inc PD-1 and PD-L1 Drug Business Overview
7.11.3 Akeso, Inc PD-1 and PD-L1 Drug Major Product Offerings
7.11.4 Akeso, Inc PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.11.5 Akeso, Inc Key News & Latest Developments
7.12 BeiGene
7.12.1 BeiGene Company Summary
7.12.2 BeiGene PD-1 and PD-L1 Drug Business Overview
7.12.3 BeiGene PD-1 and PD-L1 Drug Major Product Offerings
7.12.4 BeiGene PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.12.5 BeiGene Key News & Latest Developments
7.13 Innovent
7.13.1 Innovent Company Summary
7.13.2 Innovent PD-1 and PD-L1 Drug Business Overview
7.13.3 Innovent PD-1 and PD-L1 Drug Major Product Offerings
7.13.4 Innovent PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.13.5 Innovent Key News & Latest Developments
7.14 Jiangsu Hengrui Medicine Co.,Ltd
7.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Summary
7.14.2 Jiangsu Hengrui Medicine Co.,Ltd Business Overview
7.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Major Product Offerings
7.14.4 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.14.5 Jiangsu Hengrui Medicine Co.,Ltd Key News & Latest Developments
7.15 Cstone
7.15.1 Cstone Company Summary
7.15.2 Cstone Business Overview
7.15.3 Cstone PD-1 and PD-L1 Drug Major Product Offerings
7.15.4 Cstone PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.15.5 Cstone Key News & Latest Developments
7.16 Henlius
7.16.1 Henlius Company Summary
7.16.2 Henlius Business Overview
7.16.3 Henlius PD-1 and PD-L1 Drug Major Product Offerings
7.16.4 Henlius PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.16.5 Henlius Key News & Latest Developments
7.17 Simcere Pharmaceutical Group Limited
7.17.1 Simcere Pharmaceutical Group Limited Company Summary
7.17.2 Simcere Pharmaceutical Group Limited Business Overview
7.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Major Product Offerings
7.17.4 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales and Revenue in Global (2019-2024)
7.17.5 Simcere Pharmaceutical Group Limited Key News & Latest Developments
8 Global PD-1 and PD-L1 Drug Production Capacity, Analysis
8.1 Global PD-1 and PD-L1 Drug Production Capacity, 2019-2030
8.2 PD-1 and PD-L1 Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global PD-1 and PD-L1 Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PD-1 and PD-L1 Drug Supply Chain Analysis
10.1 PD-1 and PD-L1 Drug Industry Value Chain
10.2 PD-1 and PD-L1 Drug Upstream Market
10.3 PD-1 and PD-L1 Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 PD-1 and PD-L1 Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of PD-1 and PD-L1 Drug in Global Market
Table 2. Top PD-1 and PD-L1 Drug Players in Global Market, Ranking by Revenue (2023)
Table 3. Global PD-1 and PD-L1 Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global PD-1 and PD-L1 Drug Revenue Share by Companies, 2019-2024
Table 5. Global PD-1 and PD-L1 Drug Sales by Companies, (K Units), 2019-2024
Table 6. Global PD-1 and PD-L1 Drug Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers PD-1 and PD-L1 Drug Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers PD-1 and PD-L1 Drug Product Type
Table 9. List of Global Tier 1 PD-1 and PD-L1 Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PD-1 and PD-L1 Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global PD-1 and PD-L1 Drug Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global PD-1 and PD-L1 Drug Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global PD-1 and PD-L1 Drug Sales (K Units), 2019-2024
Table 15. By Type - Global PD-1 and PD-L1 Drug Sales (K Units), 2025-2030
Table 16. By Application ? Global PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global PD-1 and PD-L1 Drug Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global PD-1 and PD-L1 Drug Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global PD-1 and PD-L1 Drug Sales (K Units), 2019-2024
Table 20. By Application - Global PD-1 and PD-L1 Drug Sales (K Units), 2025-2030
Table 21. By Region ? Global PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global PD-1 and PD-L1 Drug Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global PD-1 and PD-L1 Drug Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global PD-1 and PD-L1 Drug Sales (K Units), 2019-2024
Table 25. By Region - Global PD-1 and PD-L1 Drug Sales (K Units), 2025-2030
Table 26. By Country - North America PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America PD-1 and PD-L1 Drug Sales, (K Units), 2019-2024
Table 29. By Country - North America PD-1 and PD-L1 Drug Sales, (K Units), 2025-2030
Table 30. By Country - Europe PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe PD-1 and PD-L1 Drug Sales, (K Units), 2019-2024
Table 33. By Country - Europe PD-1 and PD-L1 Drug Sales, (K Units), 2025-2030
Table 34. By Region - Asia PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia PD-1 and PD-L1 Drug Sales, (K Units), 2019-2024
Table 37. By Region - Asia PD-1 and PD-L1 Drug Sales, (K Units), 2025-2030
Table 38. By Country - South America PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America PD-1 and PD-L1 Drug Sales, (K Units), 2019-2024
Table 41. By Country - South America PD-1 and PD-L1 Drug Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa PD-1 and PD-L1 Drug Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa PD-1 and PD-L1 Drug Sales, (K Units), 2025-2030
Table 46. Bristol Myers Squibb Company Summary
Table 47. Bristol Myers Squibb PD-1 and PD-L1 Drug Product Offerings
Table 48. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Bristol Myers Squibb Key News & Latest Developments
Table 50. Merck & Co., Inc. Company Summary
Table 51. Merck & Co., Inc. PD-1 and PD-L1 Drug Product Offerings
Table 52. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Merck & Co., Inc. Key News & Latest Developments
Table 54. F. Hoffmann -La Roche Ltd Company Summary
Table 55. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product Offerings
Table 56. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. F. Hoffmann -La Roche Ltd Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca PD-1 and PD-L1 Drug Product Offerings
Table 60. AstraZeneca PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi PD-1 and PD-L1 Drug Product Offerings
Table 64. Sanofi PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Sanofi Key News & Latest Developments
Table 66. Pfizer Inc Company Summary
Table 67. Pfizer Inc PD-1 and PD-L1 Drug Product Offerings
Table 68. Pfizer Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Pfizer Inc Key News & Latest Developments
Table 70. Lilly Company Summary
Table 71. Lilly PD-1 and PD-L1 Drug Product Offerings
Table 72. Lilly PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Lilly Key News & Latest Developments
Table 74. Novartis AG Company Summary
Table 75. Novartis AG PD-1 and PD-L1 Drug Product Offerings
Table 76. Novartis AG PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Novartis AG Key News & Latest Developments
Table 78. GSK Company Summary
Table 79. GSK PD-1 and PD-L1 Drug Product Offerings
Table 80. GSK PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. GSK Key News & Latest Developments
Table 82. Junshi Biosciences Company Summary
Table 83. Junshi Biosciences PD-1 and PD-L1 Drug Product Offerings
Table 84. Junshi Biosciences PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Junshi Biosciences Key News & Latest Developments
Table 86. Akeso, Inc Company Summary
Table 87. Akeso, Inc PD-1 and PD-L1 Drug Product Offerings
Table 88. Akeso, Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Akeso, Inc Key News & Latest Developments
Table 90. BeiGene Company Summary
Table 91. BeiGene PD-1 and PD-L1 Drug Product Offerings
Table 92. BeiGene PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. BeiGene Key News & Latest Developments
Table 94. Innovent Company Summary
Table 95. Innovent PD-1 and PD-L1 Drug Product Offerings
Table 96. Innovent PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Innovent Key News & Latest Developments
Table 98. Jiangsu Hengrui Medicine Co.,Ltd Company Summary
Table 99. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product Offerings
Table 100. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Jiangsu Hengrui Medicine Co.,Ltd Key News & Latest Developments
Table 102. Cstone Company Summary
Table 103. Cstone PD-1 and PD-L1 Drug Product Offerings
Table 104. Cstone PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Cstone Key News & Latest Developments
Table 106. Henlius Company Summary
Table 107. Henlius PD-1 and PD-L1 Drug Product Offerings
Table 108. Henlius PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 109. Henlius Key News & Latest Developments
Table 110. Simcere Pharmaceutical Group Limited Company Summary
Table 111. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product Offerings
Table 112. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 113. Simcere Pharmaceutical Group Limited Key News & Latest Developments
Table 114. PD-1 and PD-L1 Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 115. Global PD-1 and PD-L1 Drug Capacity Market Share of Key Manufacturers, 2021-2024
Table 116. Global PD-1 and PD-L1 Drug Production by Region, 2019-2024 (K Units)
Table 117. Global PD-1 and PD-L1 Drug Production by Region, 2025-2030 (K Units)
Table 118. PD-1 and PD-L1 Drug Market Opportunities & Trends in Global Market
Table 119. PD-1 and PD-L1 Drug Market Drivers in Global Market
Table 120. PD-1 and PD-L1 Drug Market Restraints in Global Market
Table 121. PD-1 and PD-L1 Drug Raw Materials
Table 122. PD-1 and PD-L1 Drug Raw Materials Suppliers in Global Market
Table 123. Typical PD-1 and PD-L1 Drug Downstream
Table 124. PD-1 and PD-L1 Drug Downstream Clients in Global Market
Table 125. PD-1 and PD-L1 Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. PD-1 and PD-L1 Drug Segment by Type in 2023
Figure 2. PD-1 and PD-L1 Drug Segment by Application in 2023
Figure 3. Global PD-1 and PD-L1 Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global PD-1 and PD-L1 Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global PD-1 and PD-L1 Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. PD-1 and PD-L1 Drug Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by PD-1 and PD-L1 Drug Revenue in 2023
Figure 9. By Type - Global PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
Figure 11. By Type - Global PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
Figure 12. By Type - Global PD-1 and PD-L1 Drug Price (US$/Unit), 2019-2030
Figure 13. By Application - Global PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
Figure 15. By Application - Global PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
Figure 16. By Application - Global PD-1 and PD-L1 Drug Price (US$/Unit), 2019-2030
Figure 17. By Region - Global PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global PD-1 and PD-L1 Drug Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
Figure 20. By Region - Global PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
Figure 21. By Country - North America PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
Figure 22. By Country - North America PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
Figure 23. US PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Canada PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
Figure 27. By Country - Europe PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
Figure 28. Germany PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 29. France PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Italy PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 32. Russia PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
Figure 36. By Region - Asia PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
Figure 37. China PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Japan PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 41. India PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
Figure 43. By Country - South America PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
Figure 44. Brazil PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa PD-1 and PD-L1 Drug Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa PD-1 and PD-L1 Drug Sales Market Share, 2019-2030
Figure 48. Turkey PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 49. Israel PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 51. UAE PD-1 and PD-L1 Drug Revenue, (US$, Mn), 2019-2030
Figure 52. Global PD-1 and PD-L1 Drug Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production PD-1 and PD-L1 Drug by Region, 2023 VS 2030
Figure 54. PD-1 and PD-L1 Drug Industry Value Chain
Figure 55. Marketing Channels
